Spectrumdna Stock Analysis
| SPXA Stock | USD 0.01 0.00 0.00% |
SpectrumDNA holds a debt-to-equity ratio of 0.04. With a high degree of financial leverage come high-interest payments, which usually reduce SpectrumDNA's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
SpectrumDNA's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. SpectrumDNA's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps SpectrumDNA Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect SpectrumDNA's stakeholders.
For most companies, including SpectrumDNA, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for SpectrumDNA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, SpectrumDNA's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that SpectrumDNA's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which SpectrumDNA is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of SpectrumDNA to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, SpectrumDNA is said to be less leveraged. If creditors hold a majority of SpectrumDNA's assets, the Company is said to be highly leveraged.
SpectrumDNA is overvalued with Real Value of 0.008232 and Hype Value of 0.0098. The main objective of SpectrumDNA stock analysis is to determine its intrinsic value, which is an estimate of what SpectrumDNA is worth, separate from its market price. There are two main types of SpectrumDNA's stock analysis: fundamental analysis and technical analysis.
The SpectrumDNA stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and SpectrumDNA's ongoing operational relationships across important fundamental and technical indicators.
SpectrumDNA | Build AI portfolio with SpectrumDNA Stock |
SpectrumDNA Stock Analysis Notes
The company recorded a loss per share of 0.04. SpectrumDNA had not issued any dividends in recent years. Spectrum DNA, Inc. operates a social media studio that creates digital networked applications, which are engines of engagement primarily for media outlets and brand advertisers. The company was founded in 2006 and is based in Park City, Utah. Spectrumdna operates under Internet Information Providers classification in the United States and is traded on OTC Exchange. It employs 8 people. To find out more about SpectrumDNA contact Parrish Ketchmark at 435 658 1349.SpectrumDNA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. SpectrumDNA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding SpectrumDNA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| SpectrumDNA generated a negative expected return over the last 90 days | |
| SpectrumDNA has some characteristics of a very speculative penny stock | |
| SpectrumDNA has high likelihood to experience some financial distress in the next 2 years | |
| SpectrumDNA currently holds 15.83 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. SpectrumDNA has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about SpectrumDNA's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 141.25 K. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 137.17 K. | |
| SpectrumDNA currently holds about 4.22 K in cash with (1.12 M) of positive cash flow from operations. | |
| SpectrumDNA has a frail financial position based on the latest SEC disclosures |
SpectrumDNA Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 684.98 K.Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SpectrumDNA, as well as the relationship between them.SpectrumDNA Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Simple Moving Average indicator is calculated by adding the closing price of SpectrumDNA for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out SpectrumDNA short-term fluctuations and highlight longer-term trends or cycles.
SpectrumDNA Financial Rating
SpectrumDNA financial ratings play a critical role in determining how much SpectrumDNA have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for SpectrumDNA's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (8.63) | Unlikely Manipulator | View |
SpectrumDNA Debt to Cash Allocation
As SpectrumDNA follows its natural business cycle, the capital allocation decisions will not magically go away. SpectrumDNA's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
SpectrumDNA currently holds 15.83 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. SpectrumDNA has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about SpectrumDNA's use of debt, we should always consider it together with its cash and equity.SpectrumDNA Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the SpectrumDNA's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of SpectrumDNA, which in turn will lower the firm's financial flexibility.About SpectrumDNA Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how SpectrumDNA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SpectrumDNA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SpectrumDNA. By using and applying SpectrumDNA Stock analysis, traders can create a robust methodology for identifying SpectrumDNA entry and exit points for their positions.
Spectrum DNA, Inc. operates a social media studio that creates digital networked applications, which are engines of engagement primarily for media outlets and brand advertisers. The company was founded in 2006 and is based in Park City, Utah. Spectrumdna operates under Internet Information Providers classification in the United States and is traded on OTC Exchange. It employs 8 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SpectrumDNA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Complementary Tools for SpectrumDNA Stock analysis
When running SpectrumDNA's price analysis, check to measure SpectrumDNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectrumDNA is operating at the current time. Most of SpectrumDNA's value examination focuses on studying past and present price action to predict the probability of SpectrumDNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectrumDNA's price. Additionally, you may evaluate how the addition of SpectrumDNA to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |